Congressional Democrats are on the verge of passing their most significant health-care legislation in more than a decade, delivering a major victory to President Biden, who has made tackling the high price of care a key plank of his domestic agenda.

Pharma rarely loses in Washington. For years, the industry has successfully defeated US government efforts to rein in drug pricing, arguing any such moves would prevent companies from developing newer and better medicines. That argument doesn’t seem to be enough anymore.

The AMA and 60 other medical associations and national specialty societies are sounding an alarm over a federal court case being heard in the Northern District of Texas that threatens to abolish the preventive services requirement of the Affordable Care Act (ACA).

North American employers are reevaluating their employee compensation strategies as they struggle to find and keep employees in several key areas.

California’s unemployment system is too focused on rooting out fraud and minimizing business costs than providing people with timely benefits, according to a new report from the state.

The Biden administration has decided to stretch out its limited supply of monkeypox vaccine by allowing a different method of injection that uses one-fifth as much per shot, according to people familiar with the discussions. In order for the Food and Drug Administration to authorize so-called intradermal injection, which would involve injecting one-fifth of the ...